QTX3034 shrank tumors in six of 11 women with KRAS G12D-mutant endometrial cancer after several prior treatments, though the early, company-funded study has significant limitations.
Experimental KRAS Pill QTX3034 Shrinks Tumors in 6 of 11 Women With Advanced Endometrial Cancer
by | Nov 22, 2026 | Uncategorized | 0 comments

Recent Comments